Stay updated on Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 has been added to the page history, replacing the previous v3.2.0; there are no user-impact changes to page content or study data detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-26T13:48:34.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Removed a site-wide government funding and operating status notice. This change does not affect trial data or study records; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-19T08:24:55.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    New history entries were added showing updated submission dates and study status, expanding the chronological record of the trial.
    Difference
    0.0%
    Check dated 2025-10-28T05:16:49.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Added current date (2025-10-20) and a new Study Status entry (2025-10-10); removed an older date (2025-08-07). This updates time-sensitive content and study status to reflect new information.
    Difference
    0.8%
    Check dated 2025-10-21T01:32:55.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page is updated to reflect a new version (v3.2.0) and to add a prominent notice about government funding lapse and current operating status of NIH Clinical Center; the previous version reference (v3.1.0) was removed.
    Difference
    9%
    Check dated 2025-10-06T15:51:13.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.2%
    Check dated 2025-09-29T09:47:22.000Z thumbnail image

Stay in the know with updates to Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.